Cutaneous Melanoma
📧 Sign up to get email alerts when something new happens for Cutaneous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Natural History Study of Moles and Suspicious Melanoma
The National Cancer Institute-sponsored natural history study on melanocytic nevi and suspicious melanoma has completed, examining how moles…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Advanced Melanoma [Phase 1]
Phase 1 clinical trial of a melanoma vaccine therapy has completed. The study evaluated safety in patients with advanced melanoma, including…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma [NA]
Completed study evaluating toxicity and antibody responses of a KLH-conjugated bivalent GD2/GD3 vaccine with QS-DG or OPT-821 adjuvants in d…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Dinaciclib in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of dinaciclib in patients with Stage IV melanoma has results posted.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating ADI-PEG 20 plus cisplatin in metastatic melanoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) [Phase 2]
Phase I/II trial update from Japan evaluating the dabrafenib and trametinib combination in patients with BRAF V600 mutation-positive advance…
-
CLINICAL_TRIALS research · 2015-09-02Clinical Trial Update: Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients [Phase 2, Phase 3]
A Phase II/III clinical trial comparing CSF470 plus BCG plus GM-CSF versus interferon alpha-2b in patients with stage IIB/IIC and III cutane…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [Phase 1]
A Phase 1 trial evaluated a monoclonal antibody and vaccine therapy in patients with stage III or stage IV melanoma that had been surgically…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1]
This Phase 1 trial evaluates a vaccine therapy in patients with stage III or stage IV melanoma, including intraocular melanoma and cutaneous…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Dendritic Cell Vaccination During Lymphoid Reconstruction [Phase 1]
Phase 1 trial of dendritic cell vaccination during lymphoid reconstruction for uveal melanoma and cutaneous melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Expanded-access study of melphalan with the Delcath CS-PHP system for liver metastases from ocular or cutaneous melanoma is no longer availa…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating temozolomide and thalidomide in patients with stage III or stage IV melanoma, including intraocular a…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating temozolomide plus interferon alfa in patients with stage III or stage IV melanoma, including intraocular and cuta…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2b in combination with thalidomide for patients with recurrent or metastatic melanoma. Th…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluated a combination of temozolomide, thalidomide, and lomustine in patients with unresectable stage III or IV melanoma, …
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Drosophila-generated CTL [Phase 2]
Phase 2 trial update from the National Cancer Institute on Drosophila-generated cytotoxic T lymphocytes for metastatic cutaneous melanoma. T…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
A completed clinical trial examining the role of miRNA machinery in cutaneous melanoma, metastatic melanoma, and benign melanocytic nevi.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Cancer [Phase 2]
Phase 2 clinical trial update of a biological therapy for metastatic cancer has completed; the study includes kidney cancer, melanoma, and o…
-
CLINICAL_TRIALS trial_result · 2008-10-27Clinical Trial Update: Use of 852A in Metastatic Cutaneous Melanoma. [Phase 2]
Pfizer completed a Phase 2 trial evaluating the agent 852A in patients with unresectable or metastatic cutaneous melanoma.